Fennec Pharmaceuticals Inc (FENC)
$10.24 -6.48% Close Oct 30, 2026 Live
Fennec Pharmaceuticals stock today
Fennec Pharmaceuticals closed at $10.24 on October 30, 2026, down 6.48% on the day. Over the past year it returned +22.9% with dividends reinvested, against +12.4% for the S&P 500. Its market value is $356 million.
$7.50$10.00$12.50
NovJan 2026MarMayJulSep
| Period | FENC | S&P 500 (SPY) |
|---|---|---|
| 1 month | -3.8% | -0.9% |
| 3 months | +3.3% | +2.1% |
| Year to date | +33.0% | +11.7% |
| 1 year | +22.9% | +12.4% |
| 3 years | +48.8% | +88.5% |
| 5 years | +10.6% | +76.0% |
Key statistics
- Market value
- $356M
- Forward P/E
- 16.2
- Price / sales
- 6.0
- 52-week range
- $5.77 to $12.78
- Next report
- Nov 12, 2026 (estimated)
About Fennec Pharmaceuticals
Fennec Pharmaceuticals develops pharmaceutical products for cancer and rare disease treatment.
Sector: Health Care
More on Fennec Pharmaceuticals
- Financials: revenue, earnings and segmentsRevenue -6% in the year to Dec 2025
- Returns: what $1,000 became$1,000 ten years ago is $5,095 today
No forecast, no recommendation. This page describes Fennec Pharmaceuticals Inc from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.